November 22nd, 2011

Addressing the Challenges of HIV Drug Supply

From Will Stephens, Vice President, Global Access & Partnerships, Janssen Global Services, LLC

Recently, I attended the Clinton Health Access Initiative’s (CHAI) 2nd Antiretroviral (ARV) Supplier Summit in Kerala, India. Over the course of three days, CHAI brought together innovator pharmaceutical companies and generic drug manufacturers as well as civil society representatives to explore the trends and challenges of broadening HIV drug delivery.

A key theme of the summit was sustainability and suppliers’ capacity to meet the rapidly growing needs for HIV drugs. In 2005, 1.3 million people with HIV were receiving ARV treatment in low and middle-income countries; in 2009, 5.2 million were on treatment. By 2015, an estimated 15 million people will be targeted for ARV treatment.

As we heard throughout the summit, this is a challenging time for those of us working to broaden access to these medicines in resource-limited settings. The demand for safe and effective HIV drugs is increasing, while funding for HIV programs is flat or decreasing. Companies – both innovator and generic – are under constant pressure to produce safer, more effective, more convenient HIV medicines ever more cheaply.

It was clear from summit discussions that having more generic companies manufacturing HIV drugs may not always expand access and/or lower prices; and in fact, it’s likely to drive high quality, higher-priced generic manufacturers out of the market.

Read More

November 21st, 2011

National Psoriasis Awareness Campaign, Are You Serious?, Launches New Online Community

From Craig Stoltz, Director, Product Communication, Immunology, Janssen Biotech, Inc.

Last November, I posted about the launch of a national awareness campaign for people living with plaque psoriasis, called Are You Serious?TM, which you may remember featured renowned comedian Jon Lovitz. Inspired by finding a treatment that worked for him after living with psoriasis for nearly a decade, Lovitz told his psoriasis story and infused his unique style of humor into Are You Serious?TM to illustrate the everyday impact of this disease, while reinforcing the importance of having open and frank discussions with a dermatologist. 

A year later, my colleagues and I are still working on raising awareness for people with plaque psoriasis, which is the most prevalent autoimmune disease in the United States.  This year, we are shifting the Are You Serious?TM spotlight to the millions of Americans living with plaque psoriasis  — so they can share the moments that motivated them to get serious about psoriasis. Buy Kamagra Oral Jelly online 100mg Sildenafil Citrate We hope that this expansion of the conversation will give people an outlet to talk about what led them to work with a dermatologist towards effectively managing their symptoms, and will motivate others to do the same. 

Read More

November 11th, 2011

A Veteran’s Day Reflection on Mental Health

From Bill Weldon, Chairman and Chief Executive Officer, Johnson & Johnson

Each Veterans Day, Americans take a collective pause to express our gratitude for those who so honorably serve in the Armed Forces. We say a silent thank you for all who sacrificed their lives in the cause of freedom, and applaud the heroism and bravery of returning veterans whose visible wounds often bear witness to their time on the front lines. But this Veterans Day, many of our young men and women in uniform are struggling with less visible wounds: traumatic injuries that don’t require a prosthetic or wheelchair – yet leave deep and lasting scars on the mind.

The challenge of treating and curing diseases and injuries to the brain is more critical than ever.  After nine years of frequent deployments, today’s combat veterans are increasingly suffering not only traumatic brain injuries but also the emotional and psychological wounds of Post Traumatic Stress Disorder (PTSD) and other mental conditions including addiction, depression and suicide. A 2011 study of returning soldiers conducted by the National Institute on Drug Abuse found that one in five active duty and more than four in ten reserve soldiers had been diagnosed as needing mental health treatment.

Read More

November 10th, 2011

Remembering Our Veterans

From Russell Clayton, Sourcing Manager—PLDP, Johnson & Johnson World Headquarters, Co-Chair, Veterans Leadership Council

Veterans Day holds a special place in my heart. For nine years, I served as a Captain in the United States Army, Corps of Engineers and participated in Operation Iraqi Freedom in 2003.The diverse experiences I’ve had in the military have played a tremendous role in my life both personally and professionally. In the military, Order Cheapest Kamagra soft 100mg Without Prescription Sildenafil Citrate I learned not only about the value of discipline and teamwork in reaching a common goal, but also how to lead others. Today, as the co-chair of the Veterans Leadership Council (VLC), one of our affinity groups here at Johnson & Johnson, I can also say with great pride that Johnson & Johnson has a long legacy of serving and empowering its many employees who have served, and continue to serve in the military.

Johnson & Johnson employees volunteering through military service is a tradition that began in 1898 with the Spanish American War when two employees in the U.S. volunteered to serve in the military. One of those employees had just been hired at the Company, but felt it was his patriotic duty to serve his country, which the Company supported fully–even paying the employee’s salary while he served (today the Company pays the difference between the J&J and military salary).

Read More

November 10th, 2011

Health and Economic Growth at APEC

From Clifford Holland, Corporate Vice President, Government Affairs and Public Policy, Johnson & Johnson

Today I begin my first day at the 2011 Asia Pacific Economic Cooperation (APEC) CEO Summit, which brings together more than 1,500 business and government leaders from the 21 APEC member economies.  The purpose of the summit is to facilitate economic cooperation and the development of frameworks for trade, investment and regulatory policy in the region. In this global economic climate, there is a sense of urgency as leaders from the APEC countries convene to discuss prospects for recovery and long-term sustainable economic growth. Collaboration among the APEC economies is vital to creating the business environments that fuel growth and innovation. I know that at Johnson & Johnson we share the concerns of these leaders, and look forward to working together to seek solutions.

This week’s meetings will, of course, focus on policies more conducive to business investment, such as those that reduce barriers to trade and level the competitive playing field. However, it is important to note that development in the APEC economies is also tightly linked to the state of a nation’s health, or more specifically, its people’s health

Restoring and sustaining growth requires policies that recognize the role of health care as the largest sector of the global – and APEC – economies, and a prime driver of growth.

Read More

November 9th, 2011

Shedding Light on Driving in the Dark

From Gary Esterow, Senior Director, Public Relations, VISTAKON® Division of Johnson & Johnson Vision Care, Inc.

On November 6, we turned our clocks back an hour in the United States. For those of us who drive, the end of Daylight Savings Time means more time driving in the dark.

We may not be conscious of it, but when we are behind the wheel, our eyes are constantly on the move – looking at cars ahead and to the side, reading traffic signs, and checking the rearview mirror.  Then our eyes shift to objects a bit closer such as the speedometer, global navigation system and the radio. When it’s dark, these tasks can become much more difficult for some drivers.

As I’ve gotten older, I’ve noticed little changes when I am driving in low-light conditions.  I notice that glare from headlights seems to bother me a bit more and I just get this feeling that my vision could be a bit sharper. I recently went for my annual eye exam and discussed this with my optometrist. A comprehensive eye exam confirmed that my eyes were healthy.  After he checked my vision, we agreed to try a slight change in my contact lens prescription to improve my distance vision.

Read More

November 7th, 2011

Addressing Stroke Risk in Patients with Atrial Fibrillation

By Peter M. DiBattiste, M.D., Global Therapeutic Area Head, Cardiovascular and Metabolism, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

As a cardiologist and music lover, the heart’s constant and rhythmic beat has always been a passion of mine. I’m fascinated by the way that it speeds up when a person is exercising or excited, and the way it slows down during periods of rest.

Sometimes, though, the heart does not contract the way that it should. The beat can become very fast and irregular, in a condition known as atrial fibrillation. This is the most common cardiac rhythm disorder, affecting more than 2.2 million people in the United States, and may leave patients feeling weak, faint, and short of breath. Some patients may not feel any symptoms at all. The irregular heartbeat also leaves people with atrial fibrillation vulnerable to forming blood clots in the heart’s atria, which can potentially travel to the brain, resulting in a stroke.  

Patients with atrial fibrillation are at a five-fold increased risk for stroke compared with the general population. Recommended treatments are available to help reduce this risk of stroke, including medications that thin the blood to help prevent the formation of clots. Despite these recommendations, studies show that nearly half of patients with this condition do not receive appropriate medication.This is important to think about, because the results of stroke are potentially devastating, and take a serious physical, emotional, and financial toll on both the patients and their families.

Read More

November 1st, 2011

Our Statement on Baby Shampoo Ingredients in the News

From Jay Kosminsky, Vice President, Worldwide Communication and Public Affairs, Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.

Today a coalition of groups known as the Campaign for Safe Cosmetics is issuing a report critical of some of the ingredients in JOHNSON’S® Baby products. The first and most important thing to know is that the products they mention are safe – up to our own high standards and approved by regulators in the U.S., EU, and China. Still, because we know that some consumers are concerned, we have made a number of changes to our product line over the past two years. You can read more about the actions we’ve taken on the JOHNSON’S® Baby site, by clicking here.

Read More

October 27th, 2011

Celebrating Blood Bankers

From Barry Bruno, Worldwide Marketing Director, Transfusion Medicine, Ortho Clinical Diagnostics

Every two seconds, someone needs blood.  And while you’re probably familiar with how blood gets donated — and you may even know something about how blood gets transfused — you probably don’t know a lot about the people behind the scenes: the blood bankers who safeguard each unit of blood that one person gives to another. order generic levitra soft tabs 20mg vardenafil Without Prescription These unseen caretakers are responsible for ensuring that a unit of blood is screened, typed, matched and safely transported along the chain that connects the generosity of a blood donor to the need of a patient.  Every two seconds, that chain forms, and every two seconds, someone is counting on the work of a blood banker.

For more than 70 years, Ortho Clinical Diagnostics (OCD) has been serving blood bankers with products and services that help make transfusion medicine safer and more efficient.  We helped pioneer the science of blood screening in the 1940s and today, our products touch nearly 40% of the transfusions in the United States.

Since joining the team last year, I’ve had the opportunity to hear first-hand from hundreds of blood bankers around the world about what it’s like in the laboratory every day – where technology has made many routine tasks faster and easier, buy generic levitra super force Vardenafil 20mg Dapoxetine 60mg but the demand for blood continues to rise and the pace of processing blood continues to accelerate. 

Read More

October 21st, 2011

Evolving to Sustainable Solutions

In my role at Johnson & Johnson leading Public Affairs & Corporate Citizenship, I find myself in some extraordinary meetings with some amazing – even awe inspiring – people.

Yesterday was just such a day.

As watchers of Johnson & Johnson know, we’re involved in social good partnerships with NGOs, government agencies and multilateral organizations.  So I was at a USAID conference to talk about our partnerships with America’s international development agency:  why we do them, what works well and what we all can do better.

Our partnerships with USAID and others help babies breathe at birth, treat children with intestinal worms, train birth attendants, and give moms text messages on how to have a safe pregnancy and birth — all in some of the most remote and underserved places on earth.   Talking about this work, … well…it doesn’t get much better.

Yesterday, I learned that maybe it could.

As friends of Johnson & Johnson know, our social good efforts are rooted in Our Credo’s mandate to care for and be responsible to society.

There’s a practical side too. Make the world a better place; “lift up all boats,” especially the life rafts that so many people must rely on, and our company – indeed all business — will flourish too. 

Read More